---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-052234"
form_type: "8-K"
ticker: "ADVB"
cik: "0001941029"
company_name: "Advanced Biomed Inc."
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T18:44:02.886269+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Advanced Biomed secures up to $25M equity purchase agreement with Helena Global

## Summary
- Company enters purchase agreement with HELENA GLOBAL for up to $25M of common stock.
- Company may sell shares at its discretion; purchase price equals lowest intraday price during a 3-day pricing period.
- Maximum advance capped at the lesser of 25% of 5-day average daily value traded or $2M per draw.
- Investor ownership limitation set at 4.99% of outstanding common stock.
- Agreement dated June 6, 2025; shares to be sold in reliance on Section 4(a)(2) exemption.

## SEC filing metadata
- accession: 0001213900-25-052234
- form_type: 8-K
- ticker: ADVB
- cik: 0001941029
- company_name: Advanced Biomed Inc.
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1941029/000121390025052234/0001213900-25-052234-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1941029/000121390025052234/ea0243953-8k_advanced.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-052234
- JSON: https://secwatch.observer/filing/0001213900-25-052234.json
- Plain text: https://secwatch.observer/filing/0001213900-25-052234.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.